Loading...

Magalie Dosset

Title(s)Visiting Assistant Project Scientist, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
ORCID ORCID Icon0000-0002-3531-4371 Additional info
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Modulation of Determinant Factors to Improve Therapeutic Combinations with Immune Checkpoint Inhibitors. Cells. 2020 Jul 19; 9(7). Dosset M, Joseph EL, Rivera Vargas T, Apetoh L. PMID: 32707692.
      View in: PubMed   Mentions:    Fields:    
    2. Telomerase and CD4 T Cell Immunity in Cancer. Cancers (Basel). 2020 Jun 25; 12(6). Dosset M, Castro A, Carter H, Zanetti M. PMID: 32630460.
      View in: PubMed   Mentions:
    3. Immunoregulation and Clinical Implications of ANGPT2/TIE2+ M-MDSC Signature in Non-Small Cell Lung Cancer. Cancer Immunol Res. 2020 02; 8(2):268-279. Lauret Marie Joseph E, Laheurte C, Jary M, Boullerot L, Asgarov K, Gravelin E, Bouard A, Rangan L, Dosset M, Borg C, Adotévi O. PMID: 31871121.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    4. Cleaved Caspase-3 Transcriptionally Regulates Angiogenesis-Promoting Chemotherapy Resistance. Cancer Res. 2019 Dec 01; 79(23):5958-5970. Bernard A, Chevrier S, Beltjens F, Dosset M, Viltard E, Lagrange A, Derangère V, Oudot A, Ghiringhelli F, Collin B, Apetoh L, Feron O, Chen S, Arnould L, Végran F, Boidot R. PMID: 31611309.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    5. Distinct prognostic value of circulating anti-telomerase CD4+ Th1 immunity and exhausted PD-1+/TIM-3+ T cells in lung cancer. Br J Cancer. 2019 08; 121(5):405-416. Laheurte C, Dosset M, Vernerey D, Boullerot L, Gaugler B, Gravelin E, Kaulek V, Jacquin M, Cuche L, Eberst G, Jacoulet P, Fabre E, Le Pimpec-Barthes F, Tartour E, De Carvalho Bittencourt M, Westeel V, Adotévi O. PMID: 31358938.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    6. Personalized identification of tumor-associated immunogenic neoepitopes in hepatocellular carcinoma in complete remission after sorafenib treatment. Oncotarget. 2018 Oct 23; 9(83):35394-35407. Vrecko S, Guenat D, Mercier-Letondal P, Faucheu H, Dosset M, Royer B, Galaine J, Boidot R, Kim S, Jary M, Adotévi O, Borg C, Godet Y. PMID: 30459932.
      View in: PubMed   Mentions: 3     Fields:    
    7. Circulating NKp46+ Natural Killer cells have a potential regulatory property and predict distinct survival in Non-Small Cell Lung Cancer. Oncoimmunology. 2019; 8(2):e1527498. Picard E, Godet Y, Laheurte C, Dosset M, Galaine J, Beziaud L, Loyon R, Boullerot L, Lauret Marie Joseph E, Spehner L, Jacquin M, Eberst G, Gaugler B, Le Pimpec-Barthes F, Fabre E, Westeel V, Caignard A, Borg C, Adotévi O. PMID: 30713781.
      View in: PubMed   Mentions:
    8. Magalie Dosset and Thaiz Rivera Vargas. SM J Biol. 2018; 1(4):1018. Cancer therapy evolution: when genetics and epigenetics intertwine to create novel opportunities.
    9. PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer. Oncoimmunology. 2018; 7(6):e1433981. Dosset M, Vargas TR, Lagrange A, Boidot R, Végran F, Roussey A, Chalmin F, Dondaine L, Paul C, Lauret Marie-Joseph E, Martin F, Ryffel B, Borg C, Adotévi O, Ghiringhelli F, Apetoh L. PMID: 29872568.
      View in: PubMed   Mentions:
    10. Selective degradation of PU.1 during autophagy represses the differentiation and antitumour activity of TH9 cells. Nat Commun. 2017 09 15; 8(1):559. Rivera Vargas T, Cai Z, Shen Y, Dosset M, Benoit-Lizon I, Martin T, Roussey A, Flavell RA, Ghiringhelli F, Apetoh L. PMID: 28916785.
      View in: PubMed   Mentions: 13     Fields:    Translation:AnimalsCells
    11. Identification of a novel PD-L1 positive solid tumor transplantable in HLA-A*0201/DRB1*0101 transgenic mice. Oncotarget. 2017 07 25; 8(30):48959-48971. Rangan L, Galaine J, Boidot R, Hamieh M, Dosset M, Francoual J, Beziaud L, Pallandre JR, Lauret Marie Joseph E, Asgarova A, Borg C, Al Saati T, Godet Y, Latouche JB, Valmary-Degano S, Adotévi O. PMID: 28430664.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    12. Immunoprevalence and magnitude of HLA-DP4 versus HLA-DR-restricted spontaneous CD4(+) Th1 responses against telomerase in cancer patients. Oncoimmunology. 2016 May; 5(5):e1137416. Laheurte C, Galaine J, Beziaud L, Dosset M, Kerzerho J, Jacquemard C, Gaugler B, Ferrand C, Dormoy A, Aubin F, Jacoulet P, Westeel V, Borg C, Tartour E, Godet Y, Maillère B, Adotévi O. PMID: 27467955.
      View in: PubMed   Mentions:
    13. Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A*0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2/DR1 transgenic mice: steps toward polytope vaccine. PLoS One. 2014; 9(10):e108848. Seyed N, Taheri T, Vauchy C, Dosset M, Godet Y, Eslamifar A, Sharifi I, Adotevi O, Borg C, Rohrlich PS, Rafati S. PMID: 25310094.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    14. The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells. Nat Immunol. 2014 Aug; 15(8):758-66. Végran F, Berger H, Boidot R, Mignot G, Bruchard M, Dosset M, Chalmin F, Rébé C, Dérangère V, Ryffel B, Kato M, Prévost-Blondel A, Ghiringhelli F, Apetoh L. PMID: 24973819.
      View in: PubMed   Mentions: 51     Fields:    Translation:AnimalsCells
    15. Universal tumor-reactive helper peptides from telomerase as new tools for anticancer vaccination. Oncoimmunology. 2013 Mar 01; 2(3):e23430. Dosset M, Vauchy C, Beziaud L, Adotevi O, Godet Y. PMID: 23802085.
      View in: PubMed   Mentions:
    16. Targeting antitumor CD4 helper T cells with universal tumor-reactive helper peptides derived from telomerase for cancer vaccine. Hum Vaccin Immunother. 2013 May; 9(5):1073-7. Adotévi O, Dosset M, Galaine J, Beziaud L, Godet Y, Borg C. PMID: 23357860.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    17. Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer? Oncoimmunology. 2012 Dec 01; 1(9):1617-1619. Godet Y, Dosset M, Borg C, Adotevi O. PMID: 23264913.
      View in: PubMed   Mentions:
    18. Universal cancer peptide-based therapeutic vaccine breaks tolerance against telomerase and eradicates established tumor. Clin Cancer Res. 2012 Nov 15; 18(22):6284-95. Dosset M, Godet Y, Vauchy C, Beziaud L, Lone YC, Sedlik C, Liard C, Levionnois E, Clerc B, Sandoval F, Daguindau E, Wain-Hobson S, Tartour E, Langlade-Demoyen P, Borg C, Adotévi O. PMID: 23032748.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    19. Analysis of spontaneous tumor-specific CD4 T-cell immunity in lung cancer using promiscuous HLA-DR telomerase-derived epitopes: potential synergistic effect with chemotherapy response. Clin Cancer Res. 2012 May 15; 18(10):2943-53. Godet Y, Fabre E, Dosset M, Lamuraglia M, Levionnois E, Ravel P, Benhamouda N, Cazes A, Le Pimpec-Barthes F, Gaugler B, Langlade-Demoyen P, Pivot X, Saas P, Maillère B, Tartour E, Borg C, Adotévi O. PMID: 22407833.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    20. Immunogenicity of a recombinant lentiviral vector carrying human telomerase tumor antigen in HLA-B*0702 transgenic mice. Vaccine. 2010 Aug 31; 28(38):6374-81. Rusakiewicz S, Dosset M, Mollier K, Souque P, Charneau P, Wain-Hobson S, Langlade-Demoyen P, Adotévi O. PMID: 20654669.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    21. The angiogenic growth factor and biomarker midkine is a tumor-shared antigen. J Immunol. 2010 Jul 01; 185(1):418-23. Kerzerho J, Adotevi O, Castelli FA, Dosset M, Bernardeau K, Szely N, Lang F, Tartour E, Maillere B. PMID: 20511550.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    22. Targeting human telomerase reverse transcriptase with recombinant lentivector is highly effective to stimulate antitumor CD8 T-cell immunity in vivo. Blood. 2010 Apr 15; 115(15):3025-32. Adotévi O, Mollier K, Neuveut C, Dosset M, Ravel P, Fridman WH, Tartour E, Charneau P, Wain-Hobson S, Langlade-Demoyen P. PMID: 20130242.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    Magalie's Networks
    Concepts (117)
    Derived automatically from this person's publications.
    _
    Co-Authors (1)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _